We strengthen the development of the clinical research sector and highlight its role for patients, the welfare state and the country’s economy, with the aim of making Greece a strong center for conducting clinical studies with international impact.
With millions of euros invested in research and development, clinical studies and manufacturing, the pharmaceutical industry contributes directly to GDP growth, demonstrating its crucial role in achieving a dynamic growth path.
We promote, enhance and reward innovation by implementing numerous actions in collaboration with the scientific and academic community, with various state and pharmaceutical and healthcare market actors, as well as with the European Federation of Pharmaceutical Industries and Associations (EFPIA).
